naltrexone and Adrenal Hyperplasia, Congenital

naltrexone has been researched along with Adrenal Hyperplasia, Congenital in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Böttcher, B; Dörr, HG; Wildt, L	1

Other Studies

1 other study(ies) available for naltrexone and Adrenal Hyperplasia, Congenital

Article	Year
Naltrexone as a diagnostic tool to distinguish between hyperandrogenemic and hypothalamic ovarian failure in females with congenital adrenal hyperplasia due to 21-hydroxylase-deficiency (CAH). European journal of obstetrics, gynecology, and reproductive biology, 2014, Volume: 180 Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adult; Amenorrhea; Female; Humans; Hyperandrogenism; Hypothalamic Diseases; Naltrexone; Narcotic Antagonists; Oligomenorrhea; Primary Ovarian Insufficiency; Young Adult	2014

Article

Year

Naltrexone as a diagnostic tool to distinguish between hyperandrogenemic and hypothalamic ovarian failure in females with congenital adrenal hyperplasia due to 21-hydroxylase-deficiency (CAH).

European journal of obstetrics, gynecology, and reproductive biology, 2014, Volume: 180

Topics: Adolescent; Adrenal Hyperplasia, Congenital; Adult; Amenorrhea; Female; Humans; Hyperandrogenism; Hypothalamic Diseases; Naltrexone; Narcotic Antagonists; Oligomenorrhea; Primary Ovarian Insufficiency; Young Adult

2014